Additionally, profile evaluation of TGF-β1 gene polymorphisms has the potential to be used clinically as a routine pre-ablation assessment, and together with other factors including AF type and left atrial diameter, may provide a more integrated picture for physicians to evaluate the clinical status of LAF patients. The gene discussed is TGFB1; the disease is atrial fibrillation.